Results 211 to 220 of about 32,253 (267)

Large-Scale Proteomic Profiling of Incident Heart Failure and Its Subtypes in Older Adults. [PDF]

Circ Genom Precis Med
Njoroge JN, Sanders van Wijk S, Austin TR, Brody JA, Sitlani CM, Hamerton E, Bis JC, Henry A, Lumbers RT, HERMES Consortium, Seshaiah T, Shojaie A, Yang Y, Lamberson V, Yu B, Shah AM, Bansal N, Shah SJ, Tracy RP, Gerszten RE, Jennings LL, Gudmundsdottir V, Gudnason V, Emilsson V, Psaty BM, Kizer JR.   +25 more
europepmc   +1 more source

Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program. [PDF]

Circ Heart Fail
Tang AB, Li S, Li Y, Zhao J, Thomas K, Lewsey SC, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Yancy CW, Fonarow GC.   +14 more
europepmc   +1 more source

The Influence of Left Ventricular Ejection Fraction on Long-Term Survival of Patients after Transcatheter Edge-to-Edge Mitral Valve Repair.

Cardiology
Ausbuettel F, Barth S, Chatzis G, Schuett H, Sassani K, Fischer D, Mueller J, Weyand S, Fichera CF, Luesebrink U, Waechter C.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Metabolomic Profile in HFpEF vs HFrEF Patients

Journal of Cardiac Failure, 2020
Heart failure with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are associated with metabolic derangements, which may have different pathophysiological implications.In new-onset HFpEF (EF of ≥50%, n = 46) and HFrEF (EF of
Camilla Hage, Lars Löfgren, Chanchal Kumar   +2 more
exaly   +3 more sources

Promising findings for cell therapy in HFrEF

Nature Reviews Cardiology, 2023
exaly   +3 more sources

[Pharmacotherapy in HFrEF].

Deutsche medizinische Wochenschrift (1946), 2021
Since publication of the European Society guidelines for the diagnosis and treatment of acute and chronic heart failure in 2016, numerous studies provided new evidence how to further optimize heart failure therapy.Besides recent device-based therapeutic options, promising new drug developments give a glimmer of hope that the prognosis of this ...
Gülmisal, Güder, Stefan, Frantz
openaire   +1 more source